Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
PDF
News Release
Press Release - Coventry Connect Claim Profile
Claims Journal
In the News
Experts Say Identify Comorbidities Early to Control Workers’ Comp Claims Costs
Workers' Comp
Article
StateWatch Fall 2016
Workers' Comp
News Release
Genex Services Acquires OMAC - Leading IME Provider in Pacific Northwest
Acquisition Strengthens Genex IME/Peer Review Network & Offering
Workers' Comp
Podcast
Case Severity: What Factors are You Missing in Delayed RTW Cases?
WorkCompWire
Article
WorkCompWire: Mariellen Blue: Factoring Comorbidities Into Case Severity
It's no secret comorbidity factors have taken a toll on workers’ compensation.